Chemotherapy for Advanced Stage Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Chemotherapy for Advanced Stage Non-Small Cell Lung Cancer

Published:2008-09 Issue:3 Volume:20 Page:210-216
ISSN:1043-0679
Container-title:Seminars in Thoracic and Cardiovascular Surgery
language:en
Short-container-title:Seminars in Thoracic and Cardiovascular Surgery

Author:

Fathi Amir T.,Brahmer Julie R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Reference40 articles.

1. Clinical Oncology;Abeloff,2004

2. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions;Bunn;Clin Cancer Res,1998

3. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group Study;Wozniak;J Clin Oncol,1998

4. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small cell lung cancer;Sandler;J Clin Oncol,2000

5. Comparison of survival and quality of life in advanced non-small cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group Trial;Bonomi;J Clin Oncol,2000

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicarpin suppresses lung cancer cell growth in vitro and in vivo by inducing cell apoptosis;Acta Pharmaceutica;2024-03-01

2. LncRNA RP3-326I13.1 promotes cisplatin resistance in lung adenocarcinoma by binding to HSP90B and upregulating MMP13;Cell Cycle;2022-03-17

3. Radiomics in surgical oncology: applications and challenges;Computer Assisted Surgery;2021-01-01

4. Fine-needle aspiration of small pulmonary nodules yields material for reliable molecular analysis of adenocarcinomas;Journal of the American Society of Cytopathology;2016-03

5. Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer;Lung Cancer;2015-10